3-amino-5-hydroxybenzoic acid and Koch's Disease

3-amino-5-hydroxybenzoic acid has been researched along with Koch's Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Biggins, JB; Brady, SF; Braffman, N; Calle, PY; Campbell, EA; Danziger, M; Darst, SA; Fay, A; Glickman, MS; Lilic, M; Milshteyn, A; Montiel, D; Peek, J; Saito, K; Ternei, MA; Warrier, T; Woodworth, I	1

Other Studies

1 other study(ies) available for 3-amino-5-hydroxybenzoic acid and Koch's Disease

Article	Year
Rifamycin congeners kanglemycins are active against rifampicin-resistant bacteria via a distinct mechanism. Nature communications, 2018, 10-08, Volume: 9, Issue:1 Topics: Aminobenzoates; Antibiotics, Antitubercular; Bacteria; Bacterial Proteins; DNA-Directed RNA Polymerases; Drug Resistance, Bacterial; Humans; Hydroxybenzoates; Metagenomics; Molecular Structure; Mutation; Mycobacterium tuberculosis; Rifampin; Rifamycins; Soil Microbiology; Tuberculosis	2018

Article

Year

Rifamycin congeners kanglemycins are active against rifampicin-resistant bacteria via a distinct mechanism.

Nature communications, 2018, 10-08, Volume: 9, Issue:1

Topics: Aminobenzoates; Antibiotics, Antitubercular; Bacteria; Bacterial Proteins; DNA-Directed RNA Polymerases; Drug Resistance, Bacterial; Humans; Hydroxybenzoates; Metagenomics; Molecular Structure; Mutation; Mycobacterium tuberculosis; Rifampin; Rifamycins; Soil Microbiology; Tuberculosis

2018